Literature DB >> 33130927

Critical roles of macrophages in pressure overload-induced cardiac remodeling.

Dan Yang1,2,3, Han-Qing Liu4, Fang-Yuan Liu1,2,3, Nan Tang1,2,3, Zhen Guo1,2,3, Shu-Qing Ma1,2,3, Peng An1,2,3, Ming-Yu Wang1,2,3, Hai-Ming Wu1,2,3, Zheng Yang1,2,3, Di Fan5,6,7, Qi-Zhu Tang8,9,10.   

Abstract

Macrophages are integral components of the mammalian heart that show extensive expansion in response to various internal or external stimuli. After the onset of sustained pressure overload (PO), the accumulation of cardiac macrophages through local macrophage proliferation and monocyte migration has profound effects on the transition to cardiac hypertrophy and remodeling. In this review, we describe the heterogeneity and diversity of cardiac macrophages and summarize the current understanding of the important roles of macrophages in PO-induced cardiac remodeling. In addition, the possible mechanisms involved in macrophage modulation are also described. Finally, considering the significant effects of cardiac macrophages, we highlight their emerging role as therapeutic targets for alleviating pathological cardiac remodeling after PO.

Entities:  

Keywords:  Cardiac remodeling; Macrophages; Pressure overload

Mesh:

Year:  2020        PMID: 33130927     DOI: 10.1007/s00109-020-02002-w

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  86 in total

Review 1.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

Review 2.  Insights into innate immune signalling in controlling cardiac remodelling.

Authors:  Yaxing Zhang; Zan Huang; Hongliang Li
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

3.  Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function.

Authors:  Li Wang; Peng Yu; Bingying Zhou; Jiangping Song; Zheng Li; Mingzhi Zhang; Guangran Guo; Yin Wang; Xiao Chen; Leng Han; Shengshou Hu
Journal:  Nat Cell Biol       Date:  2020-01-08       Impact factor: 28.824

Review 4.  Mechanisms of physiological and pathological cardiac hypertrophy.

Authors:  Michinari Nakamura; Junichi Sadoshima
Journal:  Nat Rev Cardiol       Date:  2018-07       Impact factor: 32.419

Review 5.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 6.  The cellular immune system in the post-myocardial infarction repair process.

Authors:  Sam C Latet; Vicky Y Hoymans; Paul L Van Herck; Christiaan J Vrints
Journal:  Int J Cardiol       Date:  2014-11-05       Impact factor: 4.164

Review 7.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

8.  Cellular, structural and functional cardiac remodelling following pressure overload and unloading.

Authors:  Keith Dadson; Vera Kovacevic; Palanivel Rengasamy; Grace Ha Eun Kim; Stellar Boo; Ren-Ke Li; Isaac George; P Christian Schulze; Boris Hinz; Gary Sweeney
Journal:  Int J Cardiol       Date:  2016-04-23       Impact factor: 4.164

Review 9.  Physiological and pathological cardiac hypertrophy.

Authors:  Ippei Shimizu; Tohru Minamino
Journal:  J Mol Cell Cardiol       Date:  2016-06-02       Impact factor: 5.000

10.  Revisiting Cardiac Cellular Composition.

Authors:  Alexander R Pinto; Alexei Ilinykh; Malina J Ivey; Jill T Kuwabara; Michelle L D'Antoni; Ryan Debuque; Anjana Chandran; Lina Wang; Komal Arora; Nadia A Rosenthal; Michelle D Tallquist
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

View more
  3 in total

1.  Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages.

Authors:  Rui Yao; Lingyao Kong; Chunlei Yang; Jiaqi Du; Guojun Zhao; Yapeng Li
Journal:  Oxid Med Cell Longev       Date:  2022-04-26       Impact factor: 7.310

Review 2.  Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling.

Authors:  Ruochen Shao; Junli Li; Tianyi Qu; Yanbiao Liao; Mao Chen
Journal:  Oxid Med Cell Longev       Date:  2022-09-27       Impact factor: 7.310

Review 3.  Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy.

Authors:  Dan Yang; Han-Qing Liu; Fang-Yuan Liu; Zhen Guo; Peng An; Ming-Yu Wang; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.